<div class="pk-crumbs" data-crumbs="[{&quot;label&quot;:&quot;Drugs&quot;,&quot;href&quot;:&quot;README.md&quot;},{&quot;label&quot;:&quot;A01A&quot;,&quot;href&quot;:&quot;atc/A01A.md&quot;},{&quot;label&quot;:&quot;amphotericin B&quot;}]"></div>
<div class="pk-recnav" data-items="[{&quot;id&quot;:&quot;AmphotericinB_Atkinson1978_reference&quot;,&quot;label&quot;:&quot;Atkinson_1978_reference&quot;,&quot;href&quot;:&quot;drugs/drug_amphotericin_b/AmphotericinB_Atkinson1978_reference.md&quot;,&quot;status&quot;:&quot;built, not shipped&quot;,&quot;css&quot;:&quot;pk-badge--orange&quot;,&quot;here&quot;:false},{&quot;id&quot;:&quot;AmphotericinB_Stott2018_reference&quot;,&quot;label&quot;:&quot;Stott_2018_reference&quot;,&quot;href&quot;:&quot;drugs/drug_amphotericin_b/AmphotericinB_Stott2018_reference.md&quot;,&quot;status&quot;:&quot;needs review&quot;,&quot;css&quot;:&quot;pk-badge--orange&quot;,&quot;here&quot;:false},{&quot;id&quot;:&quot;AmphotericinB_Stott2022_reference&quot;,&quot;label&quot;:&quot;Stott_2022_reference&quot;,&quot;href&quot;:&quot;drugs/drug_amphotericin_b/AmphotericinB_Stott2022_reference.md&quot;,&quot;status&quot;:&quot;needs review&quot;,&quot;css&quot;:&quot;pk-badge--orange&quot;,&quot;here&quot;:false}]"></div>

# amphotericin B

- **generic name:** amphotericin B
- **ATC codes:** `A01AB04`, `A07AA07`, `G01AA03`, `J02AA01`
- **DrugBank:** [DB00681](https://go.drugbank.com/drugs/DB00681) · **PubChem:** [CID 5280965](https://pubchem.ncbi.nlm.nih.gov/compound/5280965)
- **molar mass:** 924.079 g/mol (C47H73NO17) — DrugBank
- **groups:** approved, investigational

## About

**Description.** Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.

**Indication.** Used to treat potentially life threatening fungal infections.

## Extraction summary

| extracted at | time | popPK e/r/o | PD e/r/o (paper) | PGx e/r/o | tokens in/out | LLM | papers | GROBID/JATS | OA/non-OA | NONMEM |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-18 00:39 | 1:12 | 3/0/0 | 0/0/0 | 0/0/0 | 25,672/2,170 | ollama / qwen3.8:27b-mtp-q8_0 | 1 | 1/0 | 1/0 | 0 |

## popPK records

| status | detail | model | model structure | params | citation | doi |
|---|---|---|---|---|---|---|
| <span class="pk-badge pk-badge--orange">built, not shipped</span><br><sub>blocking: model_quarantined: Vd left at base-class defaults</sub><br><sub>route_to: `scholar`</sub> | [Atkinson_1978_reference](drugs/drug_amphotericin_b/AmphotericinB_Atkinson1978_reference.md) | held back | 1-compartment, IV | 3 | Atkinson AJ et al., Amphotericin B pharmacokinetics in huma…, Antimicrobial agents and ch… (1978) | [10.1128/AAC.13.2.271](https://doi.org/10.1128/AAC.13.2.271) |
| <span class="pk-badge pk-badge--orange">needs review</span><br><sub>blocking: T3_param_coverage</sub><br><sub>route_to: `engineer`</sub> | [Stott_2018_reference](drugs/drug_amphotericin_b/AmphotericinB_Stott2018_reference.md) | ▶ model + simulator | 1-compartment, IV | 5 | Stott KE et al., Population Pharmacokinetic Model and Me…, Antimicrobial agents and ch… (2018) | [10.1128/AAC.02526-17](https://doi.org/10.1128/AAC.02526-17) |
| <span class="pk-badge pk-badge--orange">needs review</span><br><sub>blocking: T3_param_coverage</sub><br><sub>route_to: `engineer`</sub> | [Stott_2022_reference](drugs/drug_amphotericin_b/AmphotericinB_Stott2022_reference.md) | ▶ model + simulator | 1-compartment, IV | 3 | Stott KE et al., Population pharmacokinetics of liposoma…, The Journal of antimicrobia… (2022) | [10.1093/jac/dkac389](https://doi.org/10.1093/jac/dkac389) |

## ADME sites

Where this drug is handled, from DrugBank's curated enzymes / transporters / carriers and the KB's PGx genes, mapped to tissue through the ADME gene table. Compare it with other drugs on the [Sites & interactions](sites?drugs=amphotericin_b) page (add drugs there; the set becomes a link).

| process | tissue | actors (role) | evidence |
|---|---|---|---|
| metabolism | kidney | <sub>“…Exclusively renal…”</sub> | prose |

<details class="legend">
<summary>Badge legend — what each badge means</summary>
<table><thead><tr><th>badge</th><th>what it means</th></tr></thead><tbody><tr><td><span class="pk-badge pk-badge--green">curated</span></td><td>hand-authored by a person — an exemplar, not an extraction.</td></tr><tr><td><span class="pk-badge pk-badge--green">extracted</span></td><td>the pipeline accepted the record: every closed-form check it could run passed.</td></tr><tr><td><span class="pk-badge pk-badge--green">reviewed — candidate</span></td><td>the reviewer ran the built model against the paper's own reported values and they agree — the best automatic verdict there is.</td></tr><tr><td><span class="pk-badge pk-badge--green">accepted (caveats)</span></td><td>the model replicates the paper, but an advisory check failed — the record page names the caveat under the badge and the drug page shows it under the status.</td></tr><tr><td><span class="pk-badge pk-badge--orange">needs review</span></td><td>extracted, then a check failed or a value looks implausible. The numbers are shown as read, not endorsed.</td></tr><tr><td><span class="pk-badge pk-badge--orange">built, not shipped</span></td><td>a model was built, but a core parameter fell back to a library default, so it is not shipped.</td></tr><tr><td><span class="pk-badge pk-badge--red">rejected</span></td><td>not accepted — the record is not a compartmental model, or nothing usable was extracted.</td></tr><tr><td><span class="pk-badge pk-badge--neutral">not modelled</span></td><td>pipeline state, not a judgement: no model has been built for this record yet (likewise `not simulated`).</td></tr><tr><td><span class="pk-badge pk-badge--stale">stale</span></td><td>the reviewer's verdict predates the latest re-run of the paper — treat the status as out of date, not as current.</td></tr><tr><td><span class="pk-badge pk-badge--green">cross-checked ✓</span></td><td>every independent reader agreed on every compared field. With more than one reader the badge counts them, e.g. 'cross-checked ✓ 2/2'.</td></tr><tr><td><span class="pk-badge pk-badge--orange">cross-check: partial</span></td><td>a reader differs on a non-structural field (a population label, a flag), or the readers do not all agree with each other.</td></tr><tr><td><span class="pk-badge pk-badge--red">cross-check: disputed</span></td><td>at least one reader differs on a structural parameter — a clearance, a volume, ka, a lag. The record still holds the FIRST reading; the disagreement is a signal for a reviewer, never an automatic correction.</td></tr></tbody></table>
<p><small>The first badge is the record's <b>status</b> — what the pipeline and the reviewer concluded. A second badge, when present, is the <b>cross-check</b>: whether a model of another family, re-reading the same paper, extracted the same numbers. They are independent — a rejected record can be cross-checked, and a confirmed reading can still fail a plausibility check.</small></p>
</details>

## Coverage

- **PubMed hits:** 151 matched, 20 returned
- **screened:** 4  ·  **relevant:** 4
- **records:** 3  ·  extracted 0  ·  needs_review 3  ·  rejected 0  ·  stale 0
- **scholar-agent fallback query used:** not captured

## Full text wanted

_5 paper(s) judged relevant from the abstract, with no full text on disk — paywalled, or the resolver could not reach them. Follow the DOI, then save the PDF into `papers/` as `&lt;save as&gt;.pdf` and re-run the extraction._

| save as | citation | domain | score | DOI | PubMed | why wanted |
|---|---|---|---|---|---|---|
| `Lestner_2016.pdf` | Lestner JM et al., Population Pharmacokinetics of Liposoma…, Antimicrobial agents and ch… (2016) | popPK | 10 | [10.1128/AAC.01427-16](https://doi.org/10.1128/AAC.01427-16) | [27697762](https://pubmed.ncbi.nlm.nih.gov/27697762) | The paper describes a population PK study for liposomal amphotericin B in children, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence, which only contains the abstract. |
| `Stott_2018.pdf` | Stott KE et al., Population Pharmacokinetic Model and Me…, Antimicrobial agents and ch… (2018) | popPK | 10 | [10.1128/AAC.02526-17](https://doi.org/10.1128/AAC.02526-17) | [29735567](https://pubmed.ncbi.nlm.nih.gov/29735567) | The paper reports a population PK model for amphotericin B deoxycholate with explicit numeric values for clearance, volume, and intercompartmental rate constants in the text. |
| `Stott_2022.pdf` | Stott KE et al., Population pharmacokinetics of liposoma…, The Journal of antimicrobia… (2022) | popPK | 10 | [10.1093/jac/dkac389](https://doi.org/10.1093/jac/dkac389) | [36411251](https://pubmed.ncbi.nlm.nih.gov/36411251) | The paper reports a population PK model for liposomal amphotericin B with explicit numeric values for clearance, volume of distribution, and intercompartmental clearances. |
| `Han_2026.pdf` | Han S et al., Pharmacokinetic Equivalence of Amphosom, Clinical therapeutics (2026) | popPK | 9 | [10.1016/j.clinthera.2025.12.009](https://doi.org/10.1016/j.clinthera.2025.12.009) | [41513548](https://pubmed.ncbi.nlm.nih.gov/41513548) | The study is a population PK/bioequivalence trial for amphotericin B, but the specific numeric parameter values (CL, V, Q, etc.) are not present in the provided abstract text. |
| `Smith_2024.pdf` | Smith JS et al., Pharmacokinetics of intraarticular lipo…, Journal of veterinary pharm… (2024) | popPK | 9 | [10.1111/jvp.13442](https://doi.org/10.1111/jvp.13442) | [38557931](https://pubmed.ncbi.nlm.nih.gov/38557931) | The study reports quantitative non-compartmental PK parameters (Cmax, tmax, t1/2, MRT, Vd, AUC) for amphotericin B in goats, with all numeric values explicitly present in the text. |

<sub>queue written 2026-09-18T00:39:02.253785+00:00</sub>

## Screened and excluded

| domain | paper | verdict | relevance | extractability | reason |
|---|---|---|---|---|---|
| popPK | Dallalzadeh_2024 | irrelevant | 0 | 0 | The study is a clinical outcome analysis of a treatment regimen and does not report any pharmacokinetic parameters for amphotericin B. |
| popPK | Han_2026 | relevant | 9 | 2 | The study is a population PK/bioequivalence trial for amphotericin B, but the specific numeric parameter values (CL, V, Q, etc.) are not present in the provided abstract text. |
| popPK | Heidari-Kharaji_2024 | irrelevant | 0 | 0 | The study focuses on the in-vitro efficacy and in-vivo therapeutic outcomes of amphotericin B nanoparticles, reporting no pharmacokinetic parameters such as clearance, volume, or half-life. |
| popPK | Leroux_2021 | irrelevant | 2 | 0 | The paper is a review of population PK studies and does not report original quantitative disposition parameters for amphotericin B. |
| popPK | Lestner_2016 | relevant | 10 | 0 | The paper describes a population PK study for liposomal amphotericin B in children, but the specific numeric parameter values (CL, V, etc.) are not present in the provided evidence, which only contains the abstract. |
| popPK | Scott_2020 | irrelevant | 2 | 0 | The paper is a review article summarizing existing data rather than reporting original quantitative pharmacokinetic parameters for amphotericin B. |

---
<sub>Generated by `docs.py` (scholarv2) · newest extraction 2026-09-18 00:39 UTC</sub>
